This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Press Releases
Meet Redsense Medical at the Swiss Nordic Bio 2024
Correction: Missing MAR-lable in previous press release - "Year-End Report – January – December, 2023 Redsense Medical AB (publ)"
Year-End Report – January – December, 2023 Redsense Medical AB (publ)
Redsense Medical presents at Stora AktiedagarnaStockholm
American Association of Kidney Patients supports the Home Dialysis Risk Prevention Act
AAKP Says Medicare Should Prioritize Safety Innovation [read more]